Clinical trial
Treatment of MDEs During the Course of Psychotic Disorders With Duloxetine
NCT00224302 · Central Institute of Mental Health, Mannheim, Other · Completed
Key facts
| NCT number | NCT00224302 |
|---|---|
| Title | Treatment of MDEs During the Course of Psychotic Disorders With Duloxetine |
| Official title | Treatment of Major Depressive Episodes During the Course of Psychotic Disorders With Duloxetine |
| Lead sponsor | Central Institute of Mental Health, Mannheim, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Psychotic Disorders |
| Intervention type | Drug |
| Interventions | Duloxetine |
| Enrollment | 20 |
| Start date | Aug 1, 2005 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | Jun 4, 2008 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: